We next asked whether altering the expression of any of the four candidate NRs in melanoma cells would change melanoma responses to ICT using anti–programmed cell death protein 1 (anti–PD-1) antibodies (RMP-14 clone) as a checkpoint blockade. This evidence concerns the gene PDCD1 and melanoma.